hydrogen carbonate has been researched along with Coronary Disease in 42 studies
Bicarbonates: Inorganic salts that contain the -HCO3 radical. They are an important factor in determining the pH of the blood and the concentration of bicarbonate ions is regulated by the kidney. Levels in the blood are an index of the alkali reserve or buffering capacity.
hydrogencarbonate : The carbon oxoanion resulting from the removal of a proton from carbonic acid.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 116 patients with coronary heart disease, essential hypertension, acute and chronic glomerulonephritis and pyelonephritis, the authors observed differences in the excretion of the ions of 42K, stable potassium, 24Na, stable sodium, chlorine as well as in the value of diuresis during the administration of equimolar solutions of potassium hydrocarbonate and potassium chloride, sodium hydrocarbonate and sodium chloride labeled with 42K and 24Na respectively." | 3.67 | [Metabolism of potassium and sodium when administered with different anions to patients with ischemic heart disease and arterial hypertension]. ( Barnatskiĭ, VN; Korsunskiĭ, VN; Moiseev, AA; Stoliarov, VP; Vikhrov, NI, 1984) |
| " Similarly, no adverse changes occurred in systemic or pulmonary arterial pressures or in cardiac ejection fraction." | 2.67 | Safety of low-dose intraoperative bicarbonate therapy: a prospective, double-blind, randomized study. The Study of Perioperative Ischemia (SPI) Research Group. ( Arieff, AI; Leung, JM; Mangano, DT; Mark, NH, 1993) |
| "Cardiac arrest was induced by central venous injection of KCl 0." | 1.27 | Prolonged cardiac arrest and resuscitation in dogs: brain mitochondrial function with different artificial perfusion methods. ( Aronson, L; Evans, AT; Fox, L; Hildebrandt, JF; Hoehner, T; Huang, R; Indrieri, RJ; Johns, D; White, BC, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (69.05) | 18.7374 |
| 1990's | 10 (23.81) | 18.2507 |
| 2000's | 2 (4.76) | 29.6817 |
| 2010's | 1 (2.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paul Chubb, SA | 1 |
| Davis, WA | 1 |
| Peters, KE | 1 |
| Davis, TM | 1 |
| Mustafa, I | 1 |
| Leverve, XM | 1 |
| Nogueira, AC | 1 |
| Ast, I | 1 |
| Patone, G | 1 |
| Perschel, FH | 1 |
| Grimm, D | 1 |
| Paul, M | 1 |
| SEMPLE, T | 1 |
| DALL, JL | 1 |
| LANCASTER, WM | 1 |
| WANG, I | 1 |
| GRIGOR, K | 1 |
| PEEL, AA | 1 |
| NEUBAUER, E | 1 |
| GRAL, T | 1 |
| PETROPOULOS, PC | 1 |
| Tait, GA | 1 |
| Booker, PD | 1 |
| Wilson, GJ | 1 |
| Coles, JG | 1 |
| Steward, DJ | 1 |
| MacGregor, DC | 1 |
| Korsunskiĭ, VN | 1 |
| Moiseev, AA | 1 |
| Barnatskiĭ, VN | 1 |
| Stoliarov, VP | 1 |
| Vikhrov, NI | 1 |
| Ichihara, K | 1 |
| Haga, N | 1 |
| Abiko, Y | 1 |
| Poole-Wilson, PA | 1 |
| Thompson, RG | 1 |
| Cobb, LA | 1 |
| Mark, NH | 1 |
| Leung, JM | 1 |
| Arieff, AI | 2 |
| Mangano, DT | 1 |
| Noyez, L | 1 |
| van Son, JA | 1 |
| van der Werf, T | 1 |
| Knape, JT | 1 |
| Gimbrère, J | 1 |
| van Asten, WN | 1 |
| Lacquet, LK | 1 |
| Flameng, W | 1 |
| Uchida, Y | 1 |
| Murao, S | 1 |
| Tyers, GF | 1 |
| Todd, GJ | 1 |
| Neely, JR | 1 |
| Waldhausen, JA | 2 |
| Mankad, PS | 1 |
| Chester, AH | 1 |
| Yacoub, MH | 1 |
| Tian, GH | 1 |
| Mainwood, GW | 1 |
| Biro, GP | 1 |
| Smith, KE | 1 |
| Butler, KW | 1 |
| Lawrence, D | 1 |
| Deslauriers, R | 1 |
| Magovern, JA | 1 |
| Pae, WE | 1 |
| Murashita, T | 1 |
| Hearse, DJ | 3 |
| Avkiran, M | 1 |
| Baker, JE | 1 |
| Boerboom, LE | 1 |
| Olinger, GN | 1 |
| Galinanes, M | 1 |
| Pisarenko, OI | 1 |
| Studneva, IM | 1 |
| Shul'zhenko, VS | 1 |
| Khlopkov, VN | 1 |
| Novikov, ID | 1 |
| Kapel'ko, VI | 1 |
| Sakurada, T | 1 |
| Kuribayashi, R | 1 |
| Sekine, S | 1 |
| Aida, H | 1 |
| Seki, K | 1 |
| Goto, Y | 1 |
| Shibata, Y | 1 |
| Meguro, A | 1 |
| Hayashi, R | 1 |
| Saito, S | 1 |
| Kempsford, RD | 1 |
| Bersin, RM | 1 |
| Chatterjee, K | 1 |
| Wolfe, CL | 1 |
| Gilbert, HF | 1 |
| Brindle, KM | 1 |
| Radda, GK | 1 |
| White, BC | 1 |
| Hildebrandt, JF | 1 |
| Evans, AT | 1 |
| Aronson, L | 1 |
| Indrieri, RJ | 1 |
| Hoehner, T | 1 |
| Fox, L | 1 |
| Huang, R | 1 |
| Johns, D | 1 |
| Mochizuki, S | 1 |
| Taniguchi, M | 1 |
| Seki, S | 1 |
| Ishiki, M | 1 |
| Ozeki, T | 1 |
| Usui, T | 1 |
| Nagano, M | 1 |
| Gallandat Huet, RC | 1 |
| Karliczek, GF | 1 |
| van der Heide, JN | 1 |
| Brenken, U | 1 |
| Mooi, B | 1 |
| van der Broeke, JJ | 1 |
| Jenkins, I | 1 |
| de Geus, AF | 1 |
| Khuri, SF | 1 |
| Kloner, RA | 1 |
| Karaffa, SA | 1 |
| Marston, W | 1 |
| Taylor, AD | 1 |
| Lai, NC | 1 |
| Tow, DE | 1 |
| Barsamian, EM | 1 |
| Myers, CL | 1 |
| Weiss, SJ | 1 |
| Kirsh, MM | 1 |
| Shepard, BM | 1 |
| Shlafer, M | 1 |
| Miyazawa, T | 1 |
| Bolotova, MF | 1 |
| Moshal, MG | 1 |
| Wilke, M | 1 |
| Lolley, DM | 1 |
| Hewitt, RL | 1 |
| Drapanas, T | 1 |
| Aberman, A | 1 |
| Fulop, M | 1 |
| Brachfeld, N | 1 |
| Apstein, CS | 1 |
| Clode, M | 1 |
| Campbell, EJ | 1 |
| Hochrein, H | 1 |
| Helwing, HP | 1 |
| Gault, MH | 1 |
| Ferguson, EL | 1 |
| Sidhu, JS | 1 |
| Corbin, RP | 1 |
| Alekseev, GK | 1 |
| Martynov, IV | 1 |
| Tikhonov, AA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as a Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients[NCT00966628] | Phase 3 | 50 participants (Actual) | Interventional | 2008-05-31 | Active, not recruiting | ||
| Use of Hypertonic Versus Isotonic Solutions in Off Pump Coronary Artery Bypass Graft Surgery Targeting the Left Marginal Branch[NCT01463917] | Phase 4 | 20 participants (Anticipated) | Interventional | 2011-09-30 | Recruiting | ||
| Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill : A Multiple Center Randomized Clinical Trial (BICAR-ICU)[NCT02476253] | Phase 3 | 400 participants (Anticipated) | Interventional | 2015-05-05 | Recruiting | ||
| Custodiol-HTK Solution as a Cardioplegic Agent- A Prospective Non-Inferiority Randomized Clinical Trial[NCT01681095] | Phase 2 | 110 participants (Actual) | Interventional | 2012-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of participants with all-cause mortality AS reported in the Society of Thoracic Surgeons (STS) database after 30 days postoperative (NCT01681095)
Timeframe: 30 days post procedure
| Intervention | participants (Number) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 0 |
| Cold Blood Cardioplegia | 0 |
CK-MB measured 24 hours post-operatively (NCT01681095)
Timeframe: 24 hours post procedure
| Intervention | ng/mL (Mean) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 20 |
| Cold Blood Cardioplegia | 24 |
CK-MB measured 48 hours post-operatively (NCT01681095)
Timeframe: 48 hours post procedure
| Intervention | ng/mL (Mean) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 6.0 |
| Cold Blood Cardioplegia | 7.8 |
CK-MB measured pre-operatively (NCT01681095)
Timeframe: pre-operative
| Intervention | ng/mL (Mean) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 1.9 |
| Cold Blood Cardioplegia | 2.6 |
Number of participants with new or worsening of cardiac dysrhythmias (NCT01681095)
Timeframe: up to 36 hrs post surgery
| Intervention | participants (Number) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 24 |
| Cold Blood Cardioplegia | 30 |
Troponin-I measured 24 hours post-operative (NCT01681095)
Timeframe: 24 hours post procedure
| Intervention | ng/mL (Mean) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 5.7 |
| Cold Blood Cardioplegia | 7.8 |
Troponin-I measured 48 hours post-operative (NCT01681095)
Timeframe: 48 hours post procedure
| Intervention | ng/mL (Mean) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 3.0 |
| Cold Blood Cardioplegia | 4.8 |
Troponin-I measured pre-operatively (NCT01681095)
Timeframe: pre-operatively
| Intervention | ng/mL (Mean) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | .03 |
| Cold Blood Cardioplegia | .03 |
Number of participants with cardiovascular-related mortality AS reported in the Society of Thoracic Surgeons (STS) database after 30 days postoperative (NCT01681095)
Timeframe: 30 days post procedure
| Intervention | participants (Number) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 0 |
| Cold Blood Cardioplegia | 0 |
Creatine phosphokinase MB isoenzyme (CK-MB) difference from baseline 7 hours post surgery (NCT01681095)
Timeframe: Baseline and 7 hours post surgery
| Intervention | ng/mL (Median) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 18.8 |
| Cold Blood Cardioplegia | 22.2 |
Troponin I values, difference from baseline 7 hours post surgery (NCT01681095)
Timeframe: Baseline and 7 hours post surgery
| Intervention | ng/mL (Median) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 9.65 |
| Cold Blood Cardioplegia | 10.15 |
LV ejection fraction by TTE, difference from baseline at 24 hours post surgery (NCT01681095)
Timeframe: Baseline and 24 hours post surgery
| Intervention | % LV volume (Mean) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | -0.06 |
| Cold Blood Cardioplegia | 1.9 |
Total time in minutes on any vasopressor or inotropic agent, including norepinephrine, epinephrine, vasopressin, milrinone, dobutamine, dopamine and/or neo-synephrine (NCT01681095)
Timeframe: up to 36 hours post procedure
| Intervention | minutes (Median) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 340 |
| Cold Blood Cardioplegia | 582 |
Duration of stay in ICU, from ICU admission to ICU discharge (NCT01681095)
Timeframe: up to 100 days after admission
| Intervention | days (Median) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 3 |
| Cold Blood Cardioplegia | 3 |
Number or participants fulfilling at least two of the following 3 criteria: (1) CK-MB of 100 ug/L or more and/or troponin-I of 3.0 ug/L or more, (2) appearance of new postoperative Q waves on the EKG of more than 0.03 seconds, and (3) a new hypokinetic or akinetic area in the left or right ventricle by echocardiography. (NCT01681095)
Timeframe: up to 36 hours post procedure
| Intervention | participants (Number) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 0 |
| Cold Blood Cardioplegia | 0 |
Number of patients receiving vasopressor or inotropic infusion for greater than 20 minutes in the operating room, including norepinephrine, epinephrine, vasopressin, milrinone, dobutamine, dopamine and/or neo-synephrine. (NCT01681095)
Timeframe: during operative procedure
| Intervention | participants (Number) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 47 |
| Cold Blood Cardioplegia | 43 |
time in hours from intubation to extubation, with intervening transport to the cardiac critical care unit. (NCT01681095)
Timeframe: up to 36 hours post procedure
| Intervention | hours (Median) |
|---|---|
| Cardioplegia: Custodiol HTK Solution | 10.5 |
| Cold Blood Cardioplegia | 11.4 |
1 review available for hydrogen carbonate and Coronary Disease
| Article | Year |
|---|---|
Acidosis and contractility of heart muscle.
Topics: Acidosis; Acidosis, Respiratory; Animals; Bicarbonates; Calcium; Carbon Dioxide; Coronary Disease; D | 1982 |
4 trials available for hydrogen carbonate and Coronary Disease
| Article | Year |
|---|---|
Metabolic and hemodynamic effects of hypertonic solutions: sodium-lactate versus sodium chloride infusion in postoperative patients.
Topics: Acid-Base Equilibrium; Bicarbonates; Blood Glucose; Cardiopulmonary Bypass; Coronary Disease; Hemody | 2002 |
Metabolic and hemodynamic effects of hypertonic solutions: sodium-lactate versus sodium chloride infusion in postoperative patients.
Topics: Acid-Base Equilibrium; Bicarbonates; Blood Glucose; Cardiopulmonary Bypass; Coronary Disease; Hemody | 2002 |
Metabolic and hemodynamic effects of hypertonic solutions: sodium-lactate versus sodium chloride infusion in postoperative patients.
Topics: Acid-Base Equilibrium; Bicarbonates; Blood Glucose; Cardiopulmonary Bypass; Coronary Disease; Hemody | 2002 |
Metabolic and hemodynamic effects of hypertonic solutions: sodium-lactate versus sodium chloride infusion in postoperative patients.
Topics: Acid-Base Equilibrium; Bicarbonates; Blood Glucose; Cardiopulmonary Bypass; Coronary Disease; Hemody | 2002 |
Safety of low-dose intraoperative bicarbonate therapy: a prospective, double-blind, randomized study. The Study of Perioperative Ischemia (SPI) Research Group.
Topics: Acidosis, Lactic; Aged; Bicarbonates; Blood Gas Analysis; Blood Glucose; Calcium; Cardiac Output; Co | 1993 |
Retrograde versus antegrade delivery of cardioplegic solution in myocardial revascularization. A clinical trial in patients with three-vessel coronary artery disease who underwent myocardial revascularization with extensive use of the internal mammary art
Topics: Bicarbonates; Calcium Chloride; Cardioplegic Solutions; Contraindications; Coronary Disease; Female; | 1993 |
Clinical effect of Bretschneider-HTK and St. Thomas cardioplegia on hemodynamic performance after bypass measured using an automatic datalogging database system.
Topics: Bicarbonates; Calcium Chloride; Clinical Trials as Topic; Computers; Coronary Artery Bypass; Coronar | 1988 |
37 other studies available for hydrogen carbonate and Coronary Disease
| Article | Year |
|---|---|
Serum bicarbonate concentration and the risk of cardiovascular disease and death in type 2 diabetes: the Fremantle Diabetes Study.
Topics: Aged; Bicarbonates; Biomarkers; Chi-Square Distribution; Coronary Disease; Diabetes Mellitus, Type 2 | 2016 |
Functional effects of acute coronary occlusion and catecholinergic stimuli on the isolated normothermic hemoperfused porcine heart.
Topics: Acute Disease; Animals; Bicarbonates; Blood; Body Temperature; Coronary Disease; Female; Heart; Hear | 2003 |
THE MANAGEMENT OF MEDICAL CARDIAC ARREST.
Topics: Aortic Valve Stenosis; Bicarbonates; Coronary Disease; Diuretics; Electrocardiography; Epinephrine; | 1963 |
[CONTRIBUTION ON THE EFFECT OF HAURYDRIN ON DIURESIS AND ON THE ELECTROLYTE BALANCE].
Topics: Bicarbonates; Chlorides; Coronary Disease; Diuresis; Diuretics; Heart Failure; Humans; Potassium; Pu | 1963 |
EFFECTS OF EXSANGUINATION DURING CIRCUMFLEX CORONARY ARTERY OCCLUSION WITH OXYGENATION AT 1 AND 3 ATA.
Topics: Animals; Atmospheric Pressure; Bicarbonates; Blood Chemical Analysis; Blood Pressure; Blood Pressure | 1964 |
Effect of multidose cardioplegia and cardioplegic solution buffering on myocardial tissue acidosis.
Topics: Acidosis; Animals; Bicarbonates; Buffers; Coronary Circulation; Coronary Disease; Dogs; Heart Arrest | 1982 |
[Metabolism of potassium and sodium when administered with different anions to patients with ischemic heart disease and arterial hypertension].
Topics: Bicarbonates; Coronary Disease; Humans; Hypertension; Injections, Intravenous; Potassium; Potassium | 1984 |
Is ischemia-induced pH decrease of dog myocardium respiratory or metabolic acidosis?
Topics: Acidosis; Acidosis, Respiratory; Animals; Bicarbonates; Carbon Dioxide; Constriction, Pathologic; Co | 1984 |
Hypokalemia after resuscitation from out-of-hospital ventricular fibrillation.
Topics: Bicarbonates; Coronary Disease; Diuretics; Heart Arrest; Humans; Hypokalemia; Myocardial Infarction; | 1982 |
Acid-induced excitation of afferent cardiac sympathetic nerve fibers.
Topics: Acids; Action Potentials; Animals; Aprotinin; Bicarbonates; Coronary Disease; Dogs; Heart; Hydrochlo | 1975 |
The mechanism of myocardial protection from ischemic arrest by intracoronary tetrodotoxin administration.
Topics: Adenosine Triphosphate; Animals; Bicarbonates; Buffers; Coronary Disease; Disease Models, Animal; He | 1975 |
Ischaemic endothelial dysfunction after single or multidose cardioplegia.
Topics: Animals; Bicarbonates; Calcium Chloride; Cardioplegic Solutions; Coronary Circulation; Coronary Dise | 1992 |
The effect of high buffer cardioplegia and secondary cardioplegia on cardiac preservation and postischemic functional recovery: a 31P NMR and functional study in Langendorff perfused pig hearts.
Topics: Adenosine Triphosphate; Animals; Bicarbonates; Buffers; Calcium; Calcium Chloride; Cardioplegic Solu | 1991 |
Age-related changes in the efficacy of crystalloid cardioplegia.
Topics: Aging; Animals; Aorta; Bicarbonates; Calcium Chloride; Coronary Disease; Heart Arrest, Induced; Hemo | 1991 |
Effects of diltiazem as an additive to St Thomas's Hospital cardioplegic solution in isolated neonatal and adult rabbit hearts.
Topics: Aging; Animals; Bicarbonates; Calcium Chloride; Coronary Disease; Diltiazem; Dose-Response Relations | 1991 |
Cardioplegia-induced damage to ischemic immature myocardium is independent of oxygen availability.
Topics: Animals; Bicarbonates; Buffers; Calcium Chloride; Cardiac Output; Cardioplegic Solutions; Coronary C | 1990 |
Assessment of ischemic injury and protective interventions: the Langendorff versus the working rat heart preparation.
Topics: Animals; Bicarbonates; Calcium Chloride; Cardioplegic Solutions; Coronary Disease; Heart; Magnesium; | 1990 |
[Relation between the energy state of the myocardium and the release of products of anaerobic metabolism].
Topics: Adenosine Triphosphate; Alanine; Anaerobiosis; Animals; Bicarbonates; Buffers; Coronary Disease; Cre | 1990 |
[Clinical study on the use of retrograde cardioplegia with St. Thomas' Hospital solution].
Topics: Adult; Aorta; Aortic Valve; Bicarbonates; Calcium Chloride; Cardioplegic Solutions; Coronary Artery | 1990 |
Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
Topics: Acetates; Animals; Animals, Newborn; Bicarbonates; Calcium Chloride; Cardiac Output; Cardioplegic So | 1989 |
Metabolic and hemodynamic consequences of sodium bicarbonate administration in patients with heart disease.
Topics: Aged; Aged, 80 and over; Arteries; Bicarbonates; Blood Gas Analysis; Blood Glucose; Coronary Circula | 1989 |
Determination of buffering capacity of rat myocardium during ischemia.
Topics: Adenosine Triphosphate; Animals; Bicarbonates; Buffers; Coronary Disease; Hydrogen-Ion Concentration | 1988 |
Prolonged cardiac arrest and resuscitation in dogs: brain mitochondrial function with different artificial perfusion methods.
Topics: Animals; Bicarbonates; Brain; Coronary Disease; Dogs; Epinephrine; Heart Arrest; Heart Massage; Mito | 1985 |
Acid-base changes in ischemic myocardium and intervention with hypothermia or bicarbonate.
Topics: Acid-Base Imbalance; Animals; Bicarbonates; Calcium; Carbon Dioxide; Coronary Circulation; Coronary | 1988 |
The significance of the late fall in myocardial PCO2 and its relationship to myocardial pH after regional coronary occlusion in the dog.
Topics: Animals; Bicarbonates; Carbon Dioxide; Coronary Circulation; Coronary Disease; Dogs; Female; Hydroge | 1985 |
Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts.
Topics: Allopurinol; Animals; Bicarbonates; Blood Pressure; Calcium Chloride; Catalase; Coronary Circulation | 1986 |
[Clinical pathophysiological study of venous blood gas partial pressures and pH of organs in various diseases (author's transl)].
Topics: Adolescent; Adult; Bicarbonates; Brain; Carbon Dioxide; Cerebrovascular Circulation; Chronic Disease | 1974 |
[Changes in acid-base equilibrium in arterial blood in experimentally reversible myocardial ischemia].
Topics: Acid-Base Equilibrium; Acidosis, Respiratory; Animals; Bicarbonates; Buffers; Carbon Dioxide; Cardia | 1973 |
A study of chronic pancreatitis in Natal.
Topics: Alcoholism; Amylases; Bicarbonates; Blood Group Antigens; Calcinosis; Cholecystokinin; Chronic Disea | 1973 |
[Heart arrest. II].
Topics: Bicarbonates; Coronary Disease; Electrolytes; Heart Arrest; Heart Failure; Hydrogen-Ion Concentratio | 1973 |
Retroperfusion of the heart with a solution of glucose, insulin, and potassium during anoxic arrest.
Topics: Animals; Bicarbonates; Buffers; Cardiac Output; Coronary Circulation; Coronary Disease; Dogs; Evalua | 1974 |
The metabolic and respiratory acidosis of acute pulmonary edema.
Topics: Acidosis; Acidosis, Respiratory; Adult; Aged; Airway Obstruction; Bicarbonates; Blood Gas Analysis; | 1972 |
The influence of available substrate on contraction of the hypoxic myocardium.
Topics: Animals; Bicarbonates; Blood Pressure; Carbon Dioxide; Coronary Disease; Glucose; Glycolysis; Heart; | 1972 |
The relationship between gas exchange and changes in blood lactate concentrations during exercise.
Topics: Adult; Aged; Bicarbonates; Carbon Dioxide; Chronic Disease; Coronary Disease; Female; Humans; Lactat | 1969 |
[Shock and the treatment of its internal clinical aspects].
Topics: Acute Kidney Injury; Adrenal Cortex Hormones; Analgesics; Bicarbonates; Blood Volume; Coronary Disea | 1970 |
Fluid and electrolyte complications of peritoneal dialysis. Choice of dialysis solutions.
Topics: Acute Kidney Injury; Adult; Alkalosis; Bicarbonates; Blood; Blood Glucose; Blood Pressure; Blood Ure | 1971 |
[Treatment of cardiac rhythm and conduction disorders in terminal states].
Topics: Adult; Aged; Arrhythmias, Cardiac; Bicarbonates; Calcium Chloride; Coronary Disease; Electric Counte | 1971 |